Episode 096: Treatment of CLL
The Fellow on Call: The Heme/Onc Podcast
00:00
Advancements in CLL Treatment
This chapter explores the evolving landscape of Chronic Lymphocytic Leukemia (CLL) therapies, particularly focusing on the impact of BTK inhibitors and the comparison of obinutuzumab versus rituximab. It highlights the significance of recent trials, treatment duration, and the role of venetoclax, while addressing patient-specific considerations in treatment choices.
Transcript
Play full episode
